Steroid Tapering for Different Medical Conditions
General Principles
For patients on corticosteroids longer than 3 weeks, gradual tapering is mandatory to prevent adrenal insufficiency, while courses under 3-4 weeks can be stopped abruptly without tapering. 1, 2
Key Physiologic Considerations
- Hypothalamic-pituitary-adrenal (HPA) axis suppression should be anticipated in any patient receiving more than 7.5 mg prednisone daily for more than 3 weeks. 1
- Single daily morning dosing (before 9 AM) is preferred to minimize adrenal suppression, except when prominent night pain occurs on low doses (<5 mg daily). 1, 3
- Patients remain vulnerable to adrenal crisis during tapering and for up to 12 months after discontinuation. 1, 4
Tapering Algorithms by Initial Dose
High-Dose Tapering (>30 mg/day)
For patients starting above 30 mg/day, reduce by 5-10 mg every 1-2 weeks until reaching 10 mg/day, then slow dramatically to 1 mg every 4 weeks. 4, 5
Specific schedule:
- Weeks 1-8: Reduce from starting dose to 10 mg/day by decreasing 5-10 mg every 1-2 weeks 5
- Below 10 mg/day: Reduce by 1 mg every 4 weeks until discontinuation 1, 4
- Alternative for very slow taper: Use alternate-day dosing (e.g., 10/7.5 mg on alternating days) when below 10 mg 4, 5
Medium-Dose Tapering (10-30 mg/day)
Taper by 5 mg weekly until reaching 10 mg/day, then slow to 2.5 mg every 2-4 weeks until reaching 5 mg/day, then 1 mg every 4 weeks. 4
Low-Dose Tapering (<10 mg/day)
For patients on long-term low-dose therapy, reduce by 1 mg every 4 weeks until discontinuation. 1, 4
If 1 mg tablets unavailable, use alternate-day schedules:
Disease-Specific Tapering Protocols
Polymyalgia Rheumatica (PMR)
Start with 12.5-25 mg prednisone daily, reduce to 10 mg/day within 4-8 weeks, then taper by 1 mg every 4 weeks until discontinuation. 1
- Initial dose selection: Use 25 mg for high relapse risk/low adverse event risk; use 12.5 mg for patients with diabetes, osteoporosis, or glaucoma 1
- Intramuscular methylprednisolone (120 mg every 3 weeks initially) may be considered for women with difficult-to-control hypertension, diabetes, osteoporosis, or glaucoma 1
Giant Cell Arteritis
Initial dose 40-60 mg/day, taper to 15-20 mg/day within 2-3 months, then to ≤5 mg/day after 1 year. 4
Inflammatory Myopathies
Start with 0.5-1 mg/kg/day (typically 60-80 mg/day) and follow this structured taper: 4
- Reduce by 10 mg every 2 weeks until reaching 30 mg/day
- Reduce by 5 mg every 2 weeks until reaching 20 mg/day
- Reduce by 2.5 mg every 2 weeks until reaching 10 mg/day
- At 10 mg/day, slow to 1 mg every 2-4 weeks until completed
Autoimmune Hepatitis
For adults: Start with 30 mg/day with azathioprine, taper to 10 mg/day for maintenance. 4
When azathioprine is established (after 2-3 months):
- Reduce by 5 mg weekly until reaching 10 mg/day 4
- Then reduce by 2.5 mg every 2-4 weeks 1, 4
- Monitor aminotransferases monthly during tapering 4
For children: Start with 1-2 mg/kg/day (up to 60 mg/day), taper over 6-8 weeks to 0.1-0.2 mg/kg daily or 5 mg daily. 4
Inflammatory Bowel Disease (IBD)
Patients on prolonged corticosteroids must have a tapering course when stopping and should be warned about steroid withdrawal syndrome (weakness, nausea, arthralgia). 1
Acute Asthma Exacerbations
For acute asthma requiring hospitalization, a 7-10 day course of 40 mg prednisone daily can be stopped abruptly without tapering—tapering provides no benefit and increases side effects. 6, 7
- This applies specifically to acute exacerbations in patients not on chronic steroids 6, 7
- Research shows no difference in relapse rates between 1-week and 7-week tapers (41% vs 52%) 7
- HPA axis recovers within 1 week after short burst therapy 8
Rheumatoid Arthritis (RA)
For long-term low-dose therapy in RA, do not exceed 10 mg/day, often given as 5 mg twice daily, and taper by 1 mg every 2-4 weeks. 9
Managing Relapse During Tapering
If disease flare occurs, immediately return to the pre-relapse dose and maintain for 4-8 weeks before attempting a slower taper. 1, 4, 5
- Consider adding steroid-sparing agents (methotrexate 7.5-10 mg/week) if multiple relapses occur 4, 5
- For autoimmune hepatitis, ensure azathioprine dose is adequate (2 mg/kg/day) before aggressive steroid reduction 4
Stress Dosing Requirements
During acute illness or physiologic stress while tapering or within 12 months of discontinuation, patients require supplemental glucocorticoids. 1, 4
Practical stress dosing:
- For patients on 10 mg prednisone daily: Increase to hydrocortisone 50 mg twice daily for 3 days during acute stress 4
- For patients on high-dose therapy: Use hydrocortisone 50 mg three times daily during acute illness 4
- For minor illness: Double the current prednisone dose for 3 days 4
Monitoring During Tapering
Follow-up visits every 4-8 weeks during the first year of tapering, then every 8-12 weeks thereafter. 4, 5
At each visit, monitor for:
- Blood pressure, glycemic control, and serum potassium 1
- Disease activity markers (ESR, CRP for inflammatory conditions) 4
- Signs of adrenal insufficiency (fatigue, weakness, nausea, hypotension) 1
- Body weight, peripheral edema, cardiac insufficiency 1
- Serum lipids, blood/urine glucose, ocular pressure 1
Prophylaxis Against Steroid-Related Complications
For patients on prednisone >7.5 mg daily for more than 3 months, prescribe calcium and vitamin D supplementation. 1
Bone protection:
- Calcium 800-1000 mg/day and vitamin D 400-800 units/day 1, 9
- Bisphosphonates based on risk factors and bone mineral density (T-score threshold -1.5 for IBD patients) 1
- Consider annual IV zoledronic acid for malabsorption or GI intolerance 1
Gastric protection:
- Proton pump inhibitors or misoprostol for patients on concurrent NSAIDs 1
Infection prophylaxis:
- Vaccinations as for immunomodulatory therapy 1
- Consider co-trimoxazole 960 mg three times weekly for patients on ≥20 mg prednisolone with triple therapy 1
Critical Pitfalls to Avoid
The most common error is tapering too quickly, especially below 10 mg/day, which leads to disease flare or symptomatic adrenal insufficiency. 4, 5
- Never use 5 mg weekly reductions after 2 months of therapy—this is only appropriate for short courses 4
- Do not accelerate taper if steroid-sparing agents started less than 2-3 months ago—therapeutic levels may not be established 4
- Never stop steroids abruptly after more than 3-4 weeks of therapy—this risks adrenal crisis 1, 2
- Failing to provide stress dosing education increases risk of adrenal crisis during intercurrent illness 1, 4
- Not monitoring disease activity during tapering may miss early signs of relapse 4
Patient Education Essentials
All patients on chronic glucocorticoids should receive:
- Written tapering schedule and clear instructions 1
- Education on stress dosing for sick days 1, 4
- Warning about steroid withdrawal syndrome (weakness, nausea, arthralgia) 1
- Glucocorticoid card documenting start date, initial dose, and tapering regimen 1
- Consider medical alert bracelet for adrenal insufficiency 4
- Information accessible to general practitioners on managing intercurrent illnesses 1